4 reports

  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • Helsinn Group
  • DEXAMETHASONE - DRUG PROFILE
  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • Helsinn Group

THE ALLERGY AND IMMUNOLOGY CENTER IS HOME TO NATIONALLY AND INTERNATIONALLY RENOWNED EXPERTS AND RESEARCHERS WHO ARE ON THE FOREFRONT OF EVALUATING NEW METHODS OF ALLERGY TESTING AND TREATMENT, AND PAVING THE WAY IN THE FIELDS OF FOOD ALLERGY, DRUG

  • Chemotherapy
  • Endoscope
  • Hospital
  • Medical Device
  • Market Size

In November 2015, Taiho Pharmaceutical Co., Ltd announced that it has submitted an application for approval of the manufacture and marketing of TAC-## (bilastine), an oral anti-allergy drug, to the Japanese Ministry of Health, Labour and Welfare.

  • Chemotherapy
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • Taiho Pharmaceutical Co., Ltd.